142 related articles for article (PubMed ID: 29764055)
1. Working towards personalization in medicine: main obstacles to reaching this vision from today's perspective.
Leyens L; Horgan D; Lal JA; Steinhausen K; Satyamoorthy K; Brand A
Per Med; 2014 Sep; 11(7):641-649. PubMed ID: 29764055
[TBL] [Abstract][Full Text] [Related]
2. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
[TBL] [Abstract][Full Text] [Related]
3. The Learning-Adapting-Leveling model: from theory to hypothesis of steps for implementation of basic genome-based evidence in personalized medicine.
Lal JA; Vaidya A; Gutiérrez-Ibarluzea I; Dauben HP; Brand A
Per Med; 2013 Sep; 10(7):683-701. PubMed ID: 29768763
[TBL] [Abstract][Full Text] [Related]
4. Progress in oral personalized medicine: contribution of 'omics'.
Glurich I; Acharya A; Brilliant MH; Shukla SK
J Oral Microbiol; 2015; 7():28223. PubMed ID: 26344171
[TBL] [Abstract][Full Text] [Related]
5. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
[TBL] [Abstract][Full Text] [Related]
6. Oncotyrol--Center for Personalized Cancer Medicine: Methods and Applications of Health Technology Assessment and Outcomes Research.
Siebert U; Jahn B; Rochau U; Schnell-Inderst P; Kisser A; Hunger T; Sroczynski G; Mühlberger N; Willenbacher W; Schnaiter S; Endel G; Huber L; Gastl G;
Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):330-40. PubMed ID: 26354133
[TBL] [Abstract][Full Text] [Related]
7. Integrating precision cancer medicine into healthcare-policy, practice, and research challenges.
Bertier G; Carrot-Zhang J; Ragoussis V; Joly Y
Genome Med; 2016 Oct; 8(1):108. PubMed ID: 27776531
[TBL] [Abstract][Full Text] [Related]
8. The Emerging Role of Proteomics in Precision Medicine: Applications in Neurodegenerative Diseases and Neurotrauma.
Alaaeddine R; Fayad M; Nehme E; Bahmad HF; Kobeissy F
Adv Exp Med Biol; 2017; 1007():59-70. PubMed ID: 28840552
[TBL] [Abstract][Full Text] [Related]
9. Emerging landscape of genomics in the Electronic Health Record for personalized medicine.
Ullman-Cullere MH; Mathew JP
Hum Mutat; 2011 May; 32(5):512-6. PubMed ID: 21309042
[TBL] [Abstract][Full Text] [Related]
10. Paving the road to personalized medicine: recommendations on regulatory, intellectual property and reimbursement challenges.
Knowles L; Luth W; Bubela T
J Law Biosci; 2017 Dec; 4(3):453-506. PubMed ID: 29868182
[TBL] [Abstract][Full Text] [Related]
11. The Translational Genomics Core at Partners Personalized Medicine: Facilitating the Transition of Research towards Personalized Medicine.
Blau A; Brown A; Mahanta L; Amr SS
J Pers Med; 2016 Feb; 6(1):. PubMed ID: 26927185
[TBL] [Abstract][Full Text] [Related]
12. Bringing personalized medicine to the community through public engagement.
Etchegary H; Wilson B
Per Med; 2013 Sep; 10(7):647-659. PubMed ID: 29768762
[TBL] [Abstract][Full Text] [Related]
13. The overarching framework of translation and integration into healthcare: a case for the LAL model.
Lal JA; Morré SA; Brand A
Per Med; 2014 Jan; 11(1):41-62. PubMed ID: 29751395
[TBL] [Abstract][Full Text] [Related]
14. Implementing and using quality measures for children's health care: perspectives on the state of the practice.
Shaller D
Pediatrics; 2004 Jan; 113(1 Pt 2):217-27. PubMed ID: 14702504
[TBL] [Abstract][Full Text] [Related]
15. Regulation, reimbursement, and the long road of implementation of personalized medicine--a perspective from the United States.
Frueh FW
Value Health; 2013; 16(6 Suppl):S27-31. PubMed ID: 24034309
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiling and companion diagnostics: where is personalized medicine in cancer heading?
Verma M
Per Med; 2014 Nov; 11(8):761-771. PubMed ID: 29764045
[TBL] [Abstract][Full Text] [Related]
17. Cognitive IT-systems for big data analysis in medicine.
Isakova J
Int J Risk Saf Med; 2015; 27 Suppl 1():S108-9. PubMed ID: 26639685
[TBL] [Abstract][Full Text] [Related]
18. The new era of personalized medicine: 10 years later.
Jørgensen JT; Winther H
Per Med; 2009 Jul; 6(4):423-428. PubMed ID: 29783540
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
